1. Home
  2. ZLAB vs WRBY Comparison

ZLAB vs WRBY Comparison

Compare ZLAB & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • WRBY
  • Stock Information
  • Founded
  • ZLAB 2013
  • WRBY 2010
  • Country
  • ZLAB China
  • WRBY United States
  • Employees
  • ZLAB N/A
  • WRBY N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • WRBY Ophthalmic Goods
  • Sector
  • ZLAB Health Care
  • WRBY Health Care
  • Exchange
  • ZLAB Nasdaq
  • WRBY Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • WRBY 2.1B
  • IPO Year
  • ZLAB 2017
  • WRBY 2021
  • Fundamental
  • Price
  • ZLAB $35.49
  • WRBY $21.97
  • Analyst Decision
  • ZLAB Buy
  • WRBY Buy
  • Analyst Count
  • ZLAB 5
  • WRBY 15
  • Target Price
  • ZLAB $54.28
  • WRBY $23.33
  • AVG Volume (30 Days)
  • ZLAB 938.1K
  • WRBY 2.0M
  • Earning Date
  • ZLAB 08-05-2025
  • WRBY 08-07-2025
  • Dividend Yield
  • ZLAB N/A
  • WRBY N/A
  • EPS Growth
  • ZLAB N/A
  • WRBY N/A
  • EPS
  • ZLAB N/A
  • WRBY N/A
  • Revenue
  • ZLAB $418,326,000.00
  • WRBY $795,094,000.00
  • Revenue This Year
  • ZLAB $44.07
  • WRBY $16.13
  • Revenue Next Year
  • ZLAB $49.13
  • WRBY $13.87
  • P/E Ratio
  • ZLAB N/A
  • WRBY N/A
  • Revenue Growth
  • ZLAB 43.72
  • WRBY 13.94
  • 52 Week Low
  • ZLAB $16.01
  • WRBY $12.46
  • 52 Week High
  • ZLAB $44.34
  • WRBY $28.68
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.61
  • WRBY 58.72
  • Support Level
  • ZLAB $34.55
  • WRBY $20.85
  • Resistance Level
  • ZLAB $36.73
  • WRBY $22.52
  • Average True Range (ATR)
  • ZLAB 1.31
  • WRBY 0.76
  • MACD
  • ZLAB -0.56
  • WRBY -0.15
  • Stochastic Oscillator
  • ZLAB 10.59
  • WRBY 67.27

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: